Cure My Disease

Don't miss your cure!

 Log in / Sign up

Age matters: study tests how fisetin acts in young vs. old bodies

NCT ID NCT06796374

Recruiting now Knowledge-focused Sponsor: University Medicine Greifswald Source: ClinicalTrials.gov ↗

First seen Apr 24, 2026 · Last updated May 16, 2026 · Updated 3 times

Summary

This study looks at how the natural supplement fisetin is processed in healthy young adults (18-30 years) compared to healthy older adults (65+ years). Researchers will give a single 500 mg dose of fisetin to 80 volunteers, some fasting and some after a meal, then measure its levels in the blood. The goal is to understand if age affects how the body handles fisetin, which may guide future research on aging.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHARMACOKINETIC STUDY IN HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Clinical Pharmacology, Institute of Pharmacology at the Center of Drug Absorption and Transport (C_DAT), University Medicine Greifswald

    RECRUITING

    Greifswald, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PHARMACOKINETIC STUDY IN HEALTHY VOLUNTEERS PHARMACOKINETIC STUDY IN HEALTHY VOLUNTEERS